Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases.
暂无分享,去创建一个
M. Gillies | Fanfan Zhou | Ling Zhu | Xiaohui Fan | Ting Zhang | Shaoxue Zeng | Wojciech Chrzanowski | Yingying Chen
[1] A. Milani,et al. An Overview of Nanoparticle Protein Corona Literature , 2023, Small.
[2] Pratima Basak,et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery , 2022, Nature Protocols.
[3] R. Ge,et al. Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics , 2022, Biomedicines.
[4] Adam G. Berger,et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery , 2022, Science.
[5] V. Préat,et al. Surface Modification of Lipid-Based Nanoparticles. , 2022, ACS nano.
[6] Chi Zhang,et al. Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy , 2022, Molecules.
[7] Xianqun Fan,et al. Ocular Nanomedicine , 2022, Advanced science.
[8] M. Tokeshi,et al. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery , 2022, Journal of Controlled Release.
[9] F. Menaa,et al. Physicochemical Characterizations and Pharmacokinetic Evaluation of Pentazocine Solid Lipid Nanoparticles against Inflammatory Pain Model , 2022, Pharmaceutics.
[10] Xue Zhu,et al. Compritol solid lipid nanoparticle formulations enhance the protective effect of betulinic acid derivatives in human Müller cells against oxidative injury. , 2021, Experimental eye research.
[11] D. Khanna,et al. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson , 2022, Human vaccines & immunotherapeutics.
[12] S. Rani,et al. Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery , 2021, Pharmaceutics.
[13] D. Bokov,et al. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol , 2021, Frontiers in Bioengineering and Biotechnology.
[14] Joshua A. Jackman,et al. Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides , 2021, International journal of molecular sciences.
[15] Q. Zhou,et al. Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. , 2021, ACS nano.
[16] S. Kent,et al. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases , 2021, Acta Biomaterialia.
[17] J. F. Wright,et al. Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes , 2021, Frontiers in Immunology.
[18] K. Park,et al. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines , 2021, Vaccines.
[19] M. Gagliardi,et al. The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery , 2021, Biomedicines.
[20] B. Bui,et al. Targeted Delivery of LM22A-4 by Cubosomes Protects Retinal Ganglion Cells in An Experimental Glaucoma Model. , 2021, Acta biomaterialia.
[21] Z. Zhou,et al. Encapsulation state of messenger RNA inside lipid nanoparticles , 2021, Biophysical journal.
[22] Yue Yang,et al. CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research , 2021, Frontiers in Medicine.
[23] Lukas Farbiak,et al. Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing , 2021, Nature Materials.
[24] P. Decuzzi,et al. Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles , 2020, Bioengineering & translational medicine.
[25] Siddharth Patel,et al. The effects of PEGylation on LNP based mRNA delivery to the eye , 2020, PloS one.
[26] S. Persano,et al. Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy , 2020, Frontiers in Chemistry.
[27] M. Taipale,et al. An efficient KRAB domain for CRISPRi applications in human cells , 2020, Nature methods.
[28] Altar M. Munis. Gene Therapy Applications of Non-Human Lentiviral Vectors , 2020, Viruses.
[29] A. Chilkoti,et al. Recent trends in protein and peptide-based biomaterials for advanced drug delivery , 2020, Advanced Drug Delivery Reviews.
[30] S. Tsang,et al. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[31] A. Silva,et al. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology , 2020, Molecules.
[32] K. Xue,et al. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases , 2020, Expert opinion on investigational drugs.
[33] Livia S. Carvalho,et al. Retinal pigment epithelium and age‐related macular degeneration: A review of major disease mechanisms , 2020, Clinical & experimental ophthalmology.
[34] A. Dhar,et al. A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems , 2020, RSC advances.
[35] Yifei Huang,et al. Inhibition of retinal neovascularization by VEGF siRNA delivered via bioreducible lipid-like nanoparticles , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.
[36] Z. Strezoska,et al. CRISPR-mediated transcriptional activation with synthetic guide RNA. , 2020, Journal of biotechnology.
[37] C. Valéry,et al. Toxicity and cellular uptake of lipid nanoparticles of different structure and composition. , 2020, Journal of colloid and interface science.
[38] G. Virgili,et al. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. , 2020, The Cochrane database of systematic reviews.
[39] W. Chan,et al. An analysis of the binding function and structural organization of the protein corona. , 2020, Journal of the American Chemical Society.
[40] Qiang Cheng,et al. Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing , 2020, Nature Nanotechnology.
[41] P. Campiglia,et al. Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile , 2020, Nanomaterials.
[42] Sanjay K. S. Patel,et al. One-step hydrothermal synthesis of magnetic rice straw for effective lipase immobilization and its application in esterification reaction. , 2020, Bioresource technology.
[43] M. Manoharan,et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs , 2019, Nature Nanotechnology.
[44] S. M. Taghdisi,et al. Therapeutic applications of AS1411 aptamer, an update review. , 2019, International journal of biological macromolecules.
[45] R. Louzada,et al. In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus , 2019, International Journal of Retina and Vitreous.
[46] Y. Chau,et al. Investigating impacts of surface charge on intraocular distribution of intravitreal lipid nanoparticles. , 2019, Experimental eye research.
[47] Krishanu Saha,et al. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing , 2019, Nature Nanotechnology.
[48] S. D. De Smedt,et al. Müller cells as a target for retinal therapy. , 2019, Drug discovery today.
[49] Y. Chau,et al. Intravitreal nanoparticles for retinal delivery. , 2019, Drug discovery today.
[50] N. Farah,et al. Gold nanoparticles for multimodal high-resolution imaging of transplanted cells for retinal replacement therapy. , 2019, Nanomedicine.
[51] Gaurav Sahay,et al. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[52] Margaret A. Liu. A Comparison of Plasmid DNA and mRNA as Vaccine Technologies , 2019, Vaccines.
[53] J. Prados,et al. Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment , 2019, Nanomaterials.
[54] M. Dobrovolskaia,et al. Subchronic and Chronic Toxicity Evaluation of Inorganic Nanoparticles for Delivery Applications. , 2019, Advanced drug delivery reviews.
[55] E. Duh,et al. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[56] E. Choi,et al. Plasma and Nanomaterials: Fabrication and Biomedical Applications , 2019, Nanomaterials.
[57] Elvira N. Chegarnov,et al. Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy. , 2018, Human gene therapy.
[58] Xiaoda Yuan,et al. Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation , 2018, Pharmaceutical Research.
[59] M. Ávila,et al. Retinal changes in rabbit after intravitreal injection of sunitinib encapsulated into solid lipid nanoparticles and polymeric nanocapsules. , 2018, Arquivos brasileiros de oftalmologia.
[60] S. Solomon,et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.
[61] J. B. Demb,et al. Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas , 2018, Nature.
[62] Daniel G. Anderson,et al. Endothelial siRNA delivery in nonhuman primates using ionizable low–molecular weight polymeric nanoparticles , 2018, Science Advances.
[63] P. Campiglia,et al. Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery , 2018, Front. Pharmacol..
[64] H. Ameri. Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation , 2018, Journal of current ophthalmology.
[65] Keerang Park,et al. Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model , 2018, Molecular therapy. Methods & clinical development.
[66] Jia-You Fang,et al. Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis , 2018, Nanomaterials.
[67] U. Kompella,et al. Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[68] Yue-Wern Huang,et al. The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms , 2017, International journal of molecular sciences.
[69] Luosheng Tang,et al. Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases , 2017, Ophthalmic Research.
[70] W. Strohl,et al. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy , 2017, BioDrugs.
[71] Chao Yang,et al. Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine , 2017, Genes & diseases.
[72] Daniel G. Anderson,et al. An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model , 2017, Scientific Reports.
[73] B. Sullenger,et al. Aptamers as Therapeutics. , 2017, Annual review of pharmacology and toxicology.
[74] R. Casson,et al. A review of the mechanisms of cone degeneration in retinitis pigmentosa , 2016, Acta ophthalmologica.
[75] J. H. Kim,et al. Nanoparticle-protein complexes mimicking corona formation in ocular environment. , 2016, Biomaterials.
[76] D. Monti,et al. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[77] B. Malaekeh-Nikouei,et al. Solid Lipid Nanoparticles Improve the Diclofenac Availability in Vitreous after Intraocular Injection , 2016, Journal of drug delivery.
[78] Peng Huang,et al. Graphene-based nanomaterials for bioimaging. , 2016, Advanced drug delivery reviews.
[79] J. Flannery,et al. Wnt Regulates Proliferation and Neurogenic Potential of Müller Glial Cells via a Lin28/let-7 miRNA-Dependent Pathway in Adult Mammalian Retinas. , 2016, Cell reports.
[80] Man Li,et al. Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA , 2016, Drug delivery.
[81] M. Agbaga,et al. Cell-Specific Promoters Enable Lipid-Based Nanoparticles to Deliver Genes to Specific Cells of the Retina In Vivo , 2016, Theranostics.
[82] J. Bennett,et al. In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery. , 2016, Human molecular genetics.
[83] A. Rodríguez-Gascón,et al. Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles. , 2016, Biomaterials.
[84] James J. Collins,et al. Comparative Analysis of Cas9 Activators Across Multiple Species , 2016, Nature Methods.
[85] L. Teimoori-Toolabi,et al. Precise and efficient siRNA design: a key point in competent gene silencing , 2016, Cancer Gene Therapy.
[86] Shuai Shi,et al. Fabrication of a Micellar Supramolecular Hydrogel for Ocular Drug Delivery. , 2016, Biomacromolecules.
[87] Harshita,et al. Ceramic Nanoparticles: Fabrication Methods and Applications in Drug Delivery. , 2015, Current pharmaceutical design.
[88] A. Rodríguez-Gascón,et al. Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[89] H. Valizadeh,et al. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. , 2015, Advanced pharmaceutical bulletin.
[90] Huanqiu Liu,et al. Evaluation of biocompatibility and toxicity of biodegradable poly (DL-lactic acid) films. , 2015, American journal of translational research.
[91] Shuai Shi,et al. Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac , 2015, Scientific Reports.
[92] M. Buffelli,et al. Effective delivery of recombinant proteins to rod photoreceptors via lipid nanovesicles. , 2015, Biochemical and biophysical research communications.
[93] M. Dirin,et al. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[94] J. A. Halliday,et al. Lost in transcription: transient errors in information transfer. , 2015, Current opinion in microbiology.
[95] Tiansen Li. Leber congenital amaurosis caused by mutations in RPGRIP1. , 2015, Cold Spring Harbor perspectives in medicine.
[96] D. Lamprou,et al. Influence of cholesterol on liposome stability and on in vitro drug release , 2015, Drug Delivery and Translational Research.
[97] Li Tang,et al. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[98] Chun-Fang Xu,et al. Clinical evaluation of pazopanib eye drops versus ranibizumab intravitreal injections in subjects with neovascular age-related macular degeneration. , 2015, Ophthalmology.
[99] E. Tatum. Molecular Biology, Nucleic Acids, and the Future of Medicine , 2015, Perspectives in biology and medicine.
[100] P. Cullis,et al. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[101] H. Okada,et al. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[102] K. Sakurai,et al. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry. , 2014, Bioorganic & medicinal chemistry.
[103] Jian-xing Ma,et al. Nanoparticle-Assisted Targeted Delivery of Eye-Specific Genes to Eyes Significantly Improves the Vision of Blind Mice In Vivo , 2014, Nano letters.
[104] J. Kasprzak,et al. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[105] Daniel G. Anderson,et al. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. , 2014, Nature nanotechnology.
[106] Samir Mitragotri,et al. Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. , 2014, Nano today.
[107] J. Flannery,et al. Specific tools for targeting and expression in Müller glial cells , 2014, Molecular therapy. Methods & clinical development.
[108] A. Jagota,et al. Binding between DNA and carbon nanotubes strongly depends upon sequence and chirality. , 2014, Langmuir : the ACS journal of surfaces and colloids.
[109] A. Lambiase,et al. An update on intravitreal implants in use for eye disorders. , 2014, Drugs of today.
[110] Bulent Ozpolat,et al. Liposomal siRNA nanocarriers for cancer therapy. , 2014, Advanced drug delivery reviews.
[111] A. Díaz-Tahoces,et al. A novel cationic niosome formulation for gene delivery to the retina. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[112] Marcus Ang,et al. Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma. , 2014, ACS nano.
[113] Robert Langer,et al. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. , 2013, ACS nano.
[114] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[115] K. Falavarjani,et al. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature , 2013, Eye.
[116] David A Largaespada,et al. Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy. , 2013, Translational research : the journal of laboratory and clinical medicine.
[117] T. Weber,et al. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy. , 2013, Human gene therapy methods.
[118] Shannon M. Conley,et al. Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery , 2012, PloS one.
[119] Javed Ali,et al. Nanostructured lipid carriers system: Recent advances in drug delivery , 2012, Journal of drug targeting.
[120] Shannon M. Conley,et al. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. , 2012, The Journal of clinical investigation.
[121] Nouri Nayerossadat,et al. Viral and nonviral delivery systems for gene delivery , 2012, Advanced biomedical research.
[122] H. Kaufman,et al. Ganciclovir Ophthalmic Gel 0.15%: Safety and Efficacy of a New Treatment for Herpes Simplex Keratitis , 2012, Current eye research.
[123] E. Fernández,et al. Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis. , 2012, Human gene therapy.
[124] E. Souto,et al. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. , 2011, Colloids and surfaces. B, Biointerfaces.
[125] Sanyog Jain,et al. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle , 2011, Expert opinion on drug delivery.
[126] R. Masland. Cell populations of the retina: the Proctor lecture. , 2011, Investigative ophthalmology & visual science.
[127] S. Seal,et al. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways , 2011, Neurobiology of Disease.
[128] Qiang Zhang,et al. A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model. , 2011, Investigative ophthalmology & visual science.
[129] R. McIvor. Therapeutic delivery of mRNA: the medium is the message. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[130] M. Tolentino. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. , 2011, Survey of ophthalmology.
[131] J. H. Kim,et al. The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation. , 2011, Biomaterials.
[132] R. Jain,et al. CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies? , 2011, Clinical Cancer Research.
[133] R. Guymer,et al. Perifoveal müller cell depletion in a case of macular telangiectasia type 2. , 2010, Ophthalmology.
[134] E. Strettoi,et al. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa , 2010, Proceedings of the National Academy of Sciences.
[135] P. Gain,et al. The outer limiting membrane (OLM) revisited: clinical implications , 2010, Clinical Ophthalmology (Auckland, N.Z.).
[136] J. Hecker,et al. Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. , 2010, International journal of pharmaceutics.
[137] K. Csaky,et al. Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies. , 2009, American journal of ophthalmology.
[138] Xiang Gao,et al. Nonviral Gene Delivery: Principle, Limitations, and Recent Progress , 2009, The AAPS Journal.
[139] C. Lehr,et al. PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.
[140] Leaf Huang,et al. Nonviral methods for siRNA delivery. , 2009, Molecular pharmaceutics.
[141] D. Mcclements,et al. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). , 2009, Journal of colloid and interface science.
[142] B. Malaekeh-Nikouei,et al. PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION , 2009, Retina.
[143] Shannon M. Conley,et al. Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina , 2009, PloS one.
[144] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[145] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[146] H. Ulrich,et al. Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology , 2007, Clinical ophthalmology.
[147] A. Bevilacqua,et al. Effects of high‐pressure homogenization on the survival of Alicyclobacillus acidoterrestris in a laboratory medium , 2007, Letters in applied microbiology.
[148] F. Kabbinavar,et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. , 2007, Journal of the National Cancer Institute.
[149] J. Flannery,et al. Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors. , 2007, Investigative ophthalmology & visual science.
[150] Shubiao Zhang,et al. Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[151] G. Arden,et al. P-Glycoprotein expression in human retinal pigment epithelium cell lines. , 2006, Experimental eye research.
[152] S. L. Hyatt,et al. Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles , 2006, Gene Therapy.
[153] H. Fessi,et al. Influence of the Formulation for Solid Lipid Nanoparticles Prepared with a Membrane Contactor , 2006, Pharmaceutical development and technology.
[154] H. Fessi,et al. Preparation of solid lipid nanoparticles using a membrane contactor. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[155] J. Heyes,et al. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[156] W. Zimmer,et al. Nuclear entry of nonviral vectors , 2005, Gene Therapy.
[157] E. Gragoudas,et al. Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.
[158] Andre K. Geim,et al. Electric Field Effect in Atomically Thin Carbon Films , 2004, Science.
[159] Theresa A. Storm,et al. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. , 2004, Human gene therapy.
[160] U. Bakowsky,et al. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.
[161] M. Rimmele. Nucleic Acid Aptamers as Tools and Drugs: Recent Developments , 2003, Chembiochem : a European journal of chemical biology.
[162] Adam Bagg,et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.
[163] M. Trotta,et al. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. , 2003, International journal of pharmaceutics.
[164] Mark A. Kay,et al. Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.
[165] Sridhar Duvvuri,et al. Drug delivery to the retina: challenges and opportunities , 2003, Expert opinion on biological therapy.
[166] P. Rakoczy,et al. Adenovirus and adeno-associated virus vectors. , 2002, DNA and cell biology.
[167] R. Müller,et al. Nanostructured lipid matrices for improved microencapsulation of drugs. , 2002, International journal of pharmaceutics.
[168] J. Benoit,et al. A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers , 2002, Pharmaceutical Research.
[169] M. Moreno-Aliaga,et al. Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes. , 2002, Biochimica et biophysica acta.
[170] Y. Ogura,et al. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. , 2001, Investigative ophthalmology & visual science.
[171] W. Thoreson,et al. Expression of Multidrug Resistance-Associated Protein (MRP) in Human Retinal Pigment Epithelial Cells and Its Interaction with BAPSG, a Novel Aldose Reductase Inhibitor , 2001, Pharmaceutical Research.
[172] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[173] M. Bally,et al. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. , 2000, Journal of pharmaceutical sciences.
[174] M E Eldefrawi,et al. In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[175] B. Roehr. Fomivirsen approved for CMV retinitis. , 1998, Journal of the International Association of Physicians in AIDS Care.
[176] I. Verma,et al. Gene therapy - promises, problems and prospects , 1997, Nature.
[177] D. Curiel,et al. Characterization of a messenger RNA polynucleotide vaccine vector. , 1995, Cancer research.
[178] G. Lenzen,et al. Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA , 1993, European journal of immunology.
[179] K. Cornetta,et al. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.
[180] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[181] T. McIntosh. The effect of cholesterol on the structure of phosphatidylcholine bilayers. , 1978, Biochimica et biophysica acta.
[182] E. Korn,et al. Single bilayer liposomes prepared without sonication. , 1973, Biochimica et biophysica acta.
[183] M. Wood,et al. Antisense oligonucleotides: the next frontier for treatment of neurological disorders , 2018, Nature Reviews Neurology.
[184] Takashi Nakamura,et al. Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics. , 2017, Macromolecular bioscience.
[185] A. Joussen,et al. [Eye Drops Instead of Intravitreal Injections? The Dream of Treating Macular Diseases by Topically Administered Drugs]. , 2017, Klinische Monatsblätter für Augenheilkunde.
[186] Francesco Salvatore,et al. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.
[187] V. Préat,et al. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[188] Murali Ramamoorth,et al. Non viral vectors in gene therapy- an overview. , 2015, Journal of clinical and diagnostic research : JCDR.
[189] Wenzhong Li,et al. Non-viral gene delivery methods. , 2013, Current pharmaceutical biotechnology.
[190] R. Tiwari,et al. Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.
[191] Zhijian Wu,et al. Effect of genome size on AAV vector packaging. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[192] A. Ziady,et al. Real-time imaging of gene delivery and expression with DNA nanoparticle technologies. , 2009, Methods in molecular biology.
[193] Robert Blumenthal,et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.
[194] M. Schubert,et al. Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[195] Joan W. Miller,et al. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. , 2003, Investigative ophthalmology & visual science.
[196] L. Prescott. Doxil offers hope to KS sufferers. , 1995, Journal of the International Association of Physicians in AIDS Care.
[197] A. Bangham,et al. NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.